Mark Coleman, MD
Interventional Pain Medicine · Pikesville, MDNPI 1821095431
Payments from drug & device makers
Across 1,607 payments — averaging $795.06 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Axsome Therapeutics, Inc.$541K
- GRT US Holding, Inc.$201K
- Averitas Pharma Inc.$182K
- Curonix LLC$165K
- Vertos Medical, Inc.$116K
- Biotronik NRO, Inc.$16K
- plus $57K from 54 others
Across 8 payments — averaging $65.22 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Saluda Medical Americas, Inc.$522
What the payments were for
- Consulting fees$150,32812%
- Speaking & faculty fees$387,37530%
- Travel & lodging$118,0529%
- Food & beverage$32,4913%
- Education$160%
- Other$589,40146%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Qutenza$371,507
- StimQ Receiver Stimulator Kit Channel A US w Receiver$157,915
- Freedom 4A Receiver Kit Channel A US w Receiver$157,915
- Freedom 8A Receiver Kit Channel A US w Receiver$157,915
- StimQ Freedom-4A Receiver Kit Channel A US w/ Receiver$157,883
- StimQ Freedom 8A Receiver Kit Channel A US w Receiver$157,723
- mild Device Kit$115,713
- Prospera$15,446
- Transfasten LSF$8,189
- ZTLido$7,956
- PROCLAIM$7,689
- INTELLIS ADAPTIVESTIM$5,200
- InSpan$1,901
- SIJFuse$1,901
- FacetFuse$1,901
- NanoFuse$1,901
- Proclaim Family of SCS IPGs$1,485
- HA MINUTEMAN G3-R$1,103
- Neuromodulation Dspsbls and Accs$550
- INTELLIS$415
How this compares
$1,277,662 in reported general payments places this provider in the 95th percentile of 56 interventional pain medicine providers in Maryland.
See all interventional pain medicine providers in Maryland →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OxycontinOxycodone Hcl | 11 | $5,307 |
| Oxycodone Hcl | 204 | $4,111 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 75 | $1,686 |
| Lidocaine | 11 | $1,259 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 70 | $1,228 |
| Tramadol Hcl | 82 | $916 |
| Morphine Sulfate ErMorphine Sulfate | 44 | $874 |
| Pregabalin | 31 | $494 |
| Cephalexin | 26 | $487 |
| Cyclobenzaprine Hcl | 24 | $310 |
| Gabapentin | 31 | $269 |
Paid to pharmacies, not to this prescriber.
Other interventional pain medicine in Pikesville
- Marc LoevRockville$318K
- Anish PatelFrederick$311K
- Aneesh SinglaSalisbury$167K
- Charles SimmonsAnnapolis$73K
- Ali El-MohandesHagerstown$57K
- Michael WongBel Air$31K
- Anna IrwinBethesda$30K
- Dontese NicholsonBaltimore$27K
- Rajesh JariNottingham$26K
- Kristoffer de LaraGermantown$24K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.